Insider Buy/Sell Details for the Biotechnology Industry — September 2026
Ratio0.2:1
Daily Buy & Sell Volume
Transactions (1189)
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,539
Price
$483.20
Total Value
$743.65K
Shares Held After
326,743
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
693
Price
$482.11
Total Value
$334.10K
Shares Held After
328,282
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,354
Price
$481.20
Total Value
$651.54K
Shares Held After
328,975
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,013
Price
$480.18
Total Value
$486.43K
Shares Held After
330,329
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
601
Price
$479.06
Total Value
$287.91K
Shares Held After
331,342
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
200
Price
$477.45
Total Value
$95.49K
Shares Held After
331,943
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$476.68
Total Value
$76.27K
Shares Held After
332,143
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$475.28
Total Value
$38.02K
Shares Held After
332,303
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
680
Price
$474.46
Total Value
$322.63K
Shares Held After
332,383
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
600
Price
$473.28
Total Value
$283.97K
Shares Held After
333,063
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
280
Price
$472.43
Total Value
$132.28K
Shares Held After
333,663
% of Holdings
0.1%
Inhibrx Biosciences, Inc. (INBX)
Lappe Mark — Director
Shares
3,000
Price
$101.70
Total Value
$305.11K
Shares Held After
740,548
% of Holdings
0.4%
Inhibrx Biosciences, Inc. (INBX)
Lappe Mark — Director
Shares
1,500
Price
$98.88
Total Value
$148.32K
Shares Held After
737,548
% of Holdings
0.2%
BioNTech SE (BNTX)
Sahin Ugur — Chief Executive Officer
Shares
34,000
Price
$98.47
Total Value
$3.35M
Shares Held After
280,209
% of Holdings
10.8%
CYTOKINETICS INC (CYTK)
Blum Robert I — Director
Shares
7,500
Price
$65.46
Total Value
$490.95K
Shares Held After
278,544
% of Holdings
2.6%
Definium Therapeutics, Inc. (DFTX)
Wiley Matthew T. — Chief Commercial Officer
Shares
3,097
Price
$36.57
Total Value
$113.26K
Shares Held After
359,036
% of Holdings
0.9%
Definium Therapeutics, Inc. (DFTX)
Barrow Robert — Director
Shares
31,550
Price
$36.57
Total Value
$1.15M
Shares Held After
2,213,090
% of Holdings
1.4%
Definium Therapeutics, Inc. (DFTX)
Sullivan Mark — Chief Legal Officer
Shares
14,051
Price
$36.57
Total Value
$513.85K
Shares Held After
494,228
% of Holdings
2.8%
Definium Therapeutics, Inc. (DFTX)
Karlin Daniel — Director
Shares
10,853
Price
$36.57
Total Value
$396.89K
Shares Held After
792,846
% of Holdings
1.4%
Definium Therapeutics, Inc. (DFTX)
Roberts Brandi — Chief Financial Officer
Shares
3,377
Price
$36.57
Total Value
$123.50K
Shares Held After
394,528
% of Holdings
0.8%
Revolution Medicines, Inc. (RVMD)
Cislini Jeff — SVP&General Counsel
Shares
765
Price
$207.32
Total Value
$158.60K
Shares Held After
51,776
% of Holdings
1.5%
MEDICINOVA INC (MNOV)
3D Investment Partners Pte. Ltd. — Formerly 10% Owner
Shares
640,000
Price
$2.70
Total Value
$1.73M
Shares Held After
4,862,047
% of Holdings
11.6%
PRECISION BIOSCIENCES INC (DTIL)
Germano Geno J — Director
Shares
2,609
Price
$6.28
Total Value
$16.38K
Shares Held After
47,492
% of Holdings
5.5%
PRECISION BIOSCIENCES INC (DTIL)
Brown Melinda — Director
Shares
1,135
Price
$6.27
Total Value
$7.12K
Shares Held After
45,481
% of Holdings
2.5%
MANNKIND CORP (MNKD)
Binder Steven B. — Director
Shares
39,051
Price
$3.29
Total Value
$128.48K
Shares Held After
713,258
% of Holdings
5.2%
Inhibrx Biosciences, Inc. (INBX)
Lappe Mark — Director
Shares
2,176
Price
$99.60
Total Value
$216.73K
Shares Held After
736,048
% of Holdings
0.3%
Revolution Medicines, Inc. (RVMD)
Mancini Anthony — Chief Global Commercialization Officer
Shares
3,121
Price
$200.54
Total Value
$625.89K
Shares Held After
39,765
% of Holdings
7.3%
Inhibrx Biosciences, Inc. (INBX)
Lappe Mark — Director
Shares
3,324
Price
$98.87
Total Value
$328.63K
Shares Held After
733,872
% of Holdings
0.5%
BioNTech SE (BNTX)
Sahin Ugur — Chief Executive Officer
Shares
27,000
Price
$98.69
Total Value
$2.66M
Shares Held After
314,209
% of Holdings
7.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
632
Price
$478.95
Total Value
$302.70K
Shares Held After
324,443
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,648
Price
$478.18
Total Value
$788.04K
Shares Held After
325,075
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,280
Price
$477.19
Total Value
$610.81K
Shares Held After
326,723
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,744
Price
$476.13
Total Value
$1.31M
Shares Held After
328,003
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,613
Price
$475.28
Total Value
$766.62K
Shares Held After
330,747
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
543
Price
$474.15
Total Value
$257.46K
Shares Held After
332,360
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
800
Price
$472.89
Total Value
$378.31K
Shares Held After
332,903
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
200
Price
$471.84
Total Value
$94.37K
Shares Held After
333,703
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$470.56
Total Value
$18.82K
Shares Held After
333,903
% of Holdings
0.0%
Damora Therapeutics, Inc. (DMRA)
Jarrett Jennifer — Director
Shares
12,500
Price
$20.23
Total Value
$252.88K
Shares Held After
512,500
% of Holdings
2.4%
CYPHERPUNK TECHNOLOGIES INC. (CYPH)
Oei Khing Djien — Director
Shares
168,750
Price
$3.92
Total Value
$661.50K
Shares Held After
0
% of Holdings
100.0%
Monopar Therapeutics (MNPR)
Robinson Chandler — Director
Shares
600
Price
$89.79
Total Value
$53.87K
Shares Held After
99,267
% of Holdings
0.6%
Monopar Therapeutics (MNPR)
Robinson Chandler — Director
Shares
8,368
Price
$88.97
Total Value
$744.50K
Shares Held After
99,867
% of Holdings
7.7%
Monopar Therapeutics (MNPR)
Robinson Chandler — Director
Shares
9,638
Price
$87.96
Total Value
$847.76K
Shares Held After
108,235
% of Holdings
8.2%
Monopar Therapeutics (MNPR)
Robinson Chandler — Director
Shares
10,450
Price
$87.15
Total Value
$910.72K
Shares Held After
117,873
% of Holdings
8.1%
Revolution Medicines, Inc. (RVMD)
Mancini Anthony — Chief Global Commercialization Officer
Shares
587
Price
$200.00
Total Value
$117.40K
Shares Held After
39,765
% of Holdings
1.5%
Anixa Biosciences Inc (ANIX)
Baskies Arnold M — Director
Shares
5,000
Price
$2.76
Total Value
$13.80K
Shares Held After
140,572
% of Holdings
3.6%
Anixa Biosciences Inc (ANIX)
KUMAR AMIT — Director
Shares
7,000
Price
$2.78
Total Value
$19.46K
Shares Held After
672,000
% of Holdings
1.0%
Kura Oncology, Inc. (KURA)
Burrows Francis — Chief Scientific Officer
Shares
20,726
Price
$10.83
Total Value
$224.51K
Shares Held After
42,327
% of Holdings
32.9%
Oric Pharmaceuticals, Inc. (ORIC)
Piscitelli Dominic — Chief Financial Officer
Shares
500
Price
$13.51
Total Value
$6.75K
Shares Held After
69,828
% of Holdings
0.7%
Oric Pharmaceuticals, Inc. (ORIC)
Piscitelli Dominic — Chief Financial Officer
Shares
100
Price
$13.50
Total Value
$1.35K
Shares Held After
70,328
% of Holdings
0.1%
Showing 201–250 of 1189 transactions (page 5 of 24)